Skip to content

Drug interactions

Eribulin + Fingolimod

Severity: Major

Eribulin and Fingolimod: major interaction.

Last updated Sources: US FDA label

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Eribulin can prolong the QT interval, and fingolimod causes bradycardia and may also affect QT. The combination increases the risk of serious ventricular arrhythmia.

What this interaction means in plain words

Eribulin and Fingolimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Eribulin belongs to Oncology; Fingolimod belongs to Central Nervous System.

Evidence level: Low

Why it happens

Additive QT prolongation aggravated by bradycardia.

What to do

Obtain a baseline ECG and correct electrolytes before eribulin. Monitor ECG and heart rate periodically, and seek cardiology advice if QTc is prolonged.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Eribulin and Fingolimod, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

References

Frequently asked questions

Can I take Eribulin with Fingolimod?

MediHelp rates the interaction as major. Eribulin and Fingolimod can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Eribulin can prolong the QT interval, and fingolimod causes bradycardia and may also affect QT. The combination increases the risk of serious ventricular arrhythmia.

How serious is the interaction between Eribulin and Fingolimod?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Obtain a baseline ECG and correct electrolytes before eribulin. Monitor ECG and heart rate periodically, and seek cardiology advice if QTc is prolonged.

What other medicines interact with Fingolimod?

MediHelp also lists interactions of Fingolimod with, for example, Adenovirus types 4 and 7 live, Bcg vaccine live, Pimozide. The full list is on the Fingolimod page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in